Conference abstract · 24 Sep 2018
Conference abstractPublished 26 Jun 2017
Inhibition effects of Tarragon (Artemisia dracunculus L.) extracts and its metabolites against the Carbonic anhydrase I and II isozymes
Agri Ibrahim Cecen University, Turkey Kilis 7 Aralik University, Turkey Ataturk University, Turkey
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Tarragon, Artemisia dracunculus L. is a small shrub and perennial plant species. It spreads in Japan, India, Iran, Europe, North America and China. The plant has several medicinal properties. It used in making vinegar and salad. In this study, five metabolites were isolated from dichloromethane extract from tarragon and their the chemical structure was characterized as anethole (1), Ã?²-stigmasterol (2), herniarin (3), (2E,4E)-N-isobutylundeca-2,4-dien-8,10-diynamide (4) and (2E,4E)-1- (piperidin-1-yl)undeca-2,4-diene-8,10-diyn-1-one (5) by IR, 1D and 2D NMR spectroscopic methods. Enzyme inhibition activities of ethanol, dichloromethane, n-hexane and methanol extracts of A. dracunculus L. and all of the pure metabolites were investigated against human carbonic anhydrase I and II isoenzymes. Enzyme inhibition effects of the extracts and pure metabolites were evaluated by comparison of their IC50 values for the first time in this study. Our results showed that the extracts and the pure compounds of A. dracunculus L. were found to be strong inhibitor against the human carbonic anhydrase I and II isoenzymes. The compounds and extracts were showed in the range of 8.65-486.2 Ã?¼M of IC50 values for Carbonic anhydrase I and II.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 2020
Morphology and productivity of tarragon (Artemisia dracunculus L.) in Central Polissya (Ukraine)
Conference abstract · 2014
Inhibition of human carbonic anhydrase isozymes I, II, IX and XII with a new series of sulfonamides incorporating aroylhydrazone-, [1,2,4]triazolo[3,4 b][1,3,4]thiadiazinyl- or 2-(cyanophenylmethylene)- 1,3,4-thiadiazol-
Article · 29 Apr 2024
Triazole Benzene Sulfonamides as Leads for Human Carbonic Anhydrase IX Inhibition: Updates on Research Progress
Conference abstract · 18 Aug 2020
Discovery of curcumin heterocyclics containing sulphonamides for carbonic anhydrase inhibition and molecular docking studies
More from this journal
The newest in Pharmaceutical Regulatory Affairs: Open Access.
Article · 13 Feb 2026
Regulatory Scenario of Pharmaceuticals during COVID-19 Pandemic in India
Article · 11 Feb 2026
EU GMP Annex 1 of 2022: A View in Depth
Article · 11 Feb 2026
Standard Formats Used in Drug Regulatory Submissions and Software Used
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Regulatory Affairs: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Tuba Aydin”
- BylineArticles whose byline prints “Bayram Yurtvermez”
- BylineArticles whose byline prints “Ahmet Cakir”
- BylineArticles whose byline prints “Murat Senturk”
- BylineArticles whose byline prints “Caviz Kazaz”

